BST1 and early-onset autosomal dominant Alzheimer disease: Moreover, CD157/BST-1 is associated with neuropsychiatric disorders, such as Parkinson’s disease, autism spectrum disorder (ASD), rapid eye movement sleep behavior disorder, major depressive disorder, restless leg syndrome/Willis–Ekbom disease, and Alzheimer’s disease [19].